NCT00788801View on ClinicalTrials.gov

Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

March 31, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

ABT-614

Baseline PET scan with radiotracer only, PET scan with radiotracer and ABT-614 Low Dose or ABT-614 High Dose

Trial Locations (2)

M5T 1R8

Site Reference ID/Investigator# 12201, Toronto

M5V 2T3

Site Reference ID/Investigator# 13961, Toronto

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00788801 - Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain | Biotech Hunter | Biotech Hunter